Cel-Sci responds to US FDA clinical hold on Multikine study
Cel-Sci has responded to the partial clinical hold imposed on a Phase III trial of its candidate head and neck cancer cell therapy Multikine in September.
Archives for November 22, 2016
One down, five to go: Autolus takes space at UK cell & gene therapy centre
T-cell immunotherapy firm Autolus has become the first tenant at the Cell and Gene Therapy (CGT) Catapult manufacturing facility in the UK.
Oxford Genetics to address viral vector scalability with Innovate UK grant
Oxford Genetics is looking to overcome the inefficient and costly scale-up of viral vector production through a $1m grant to develop new cell lines.
Lyophilised biologic reconstitution IP up for grabs after XstalBio folds
A technology developed to reduce time and increase safety when reconstituting lyophilised biologics has been put for up for sale after XstalBio's insolvency.